Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use

This publication has 96 references indexed in Scilit:

• Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
  Translational Psychiatry, 2012
• Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
  British Journal of Pharmacology, 2011
• Stimulant Abuse: Pharmacology, Cocaine, Methamphetamine, Treatment, Attempts at Pharmacotherapy
  Primary Care: Clinics in Office Practice, 2011
• Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
  Neuropsychopharmacology, 2011
• Epidemiology of HIV Among Injecting and Non-injecting Drug Users: Current Trends and Implications for Interventions
  Current HIV/AIDS Reports, 2010
• Food insufficiency among HIV-infected crack-cocaine users in Atlanta and Miami
  Public Health Nutrition, 2010
• The role of anxiety sensitivity and difficulties in emotion regulation in posttraumatic stress disorder among crack/cocaine dependent patients in residential substance abuse treatment
  Journal of Anxiety Disorders, 2009
• Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals
  Drug and Alcohol Dependence, 2009
• Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women
  AIDS, 2008
• Non-injection drug use and Hepatitis C Virus: A systematic review
  Drug and Alcohol Dependence, 2007